Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience

About

A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Articles from Mary Thompson:

Business Strategies

As CGM Options Expand, Innovators See an Edge

The continuous glucose monitoring market is dominated by Abbott, Dexcom, and Medtronic, but this $10+ billion worldwide opportunity has attracted several others, including two innovative start-ups—Biolinq and Allez Health—that closed on substantial investment rounds this year and one longstanding competitor, Senseonics, that recently launched the first year-long CGM implantable.

Read Article